GW Henssler & Associates Ltd. Buys 28,474 Shares of Amdocs Limited $DOX

Key Points

• GW Henssler & Associates Ltd. increased its stake in Amdocs Limited by 37.6% during the 1st quarter, now holding approximately 0.09% of the company worth $9.53 million.
• Amdocs reported earnings of $1.72 EPS for the last quarter, slightly beating analysts' expectations, but experienced an 8.4% year-over-year revenue decline.
• The company announced a quarterly dividend of $0.527 per share, resulting in an annualized dividend yield of 2.5%.

GW Henssler & Associates Ltd. lifted its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 37.6% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 104,190 shares of the technology company's stock after purchasing an additional 28,474 shares during the quarter. GW Henssler & Associates Ltd. owned 0.09% of Amdocs worth $9,533,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Cornerstone Planning Group LLC bought a new stake in shares of Amdocs during the 1st quarter worth $27,000. AdvisorNet Financial Inc lifted its position in shares of Amdocs by 382.9% during the 1st quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock worth $31,000 after buying an additional 268 shares during the last quarter. NBC Securities Inc. bought a new stake in shares of Amdocs during the 1st quarter worth $31,000. Quarry LP lifted its position in shares of Amdocs by 42.2% during the 1st quarter. Quarry LP now owns 391 shares of the technology company's stock worth $36,000 after buying an additional 116 shares during the last quarter. Finally, Cullen Frost Bankers Inc. bought a new stake in shares of Amdocs during the 1st quarter worth $39,000. 92.02% of the stock is currently owned by institutional investors.

Amdocs Trading Up 1.7%

Amdocs stock traded up $1.40 during trading hours on Friday, hitting $86.00. The stock had a trading volume of 558,592 shares, compared to its average volume of 883,180. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The stock has a market cap of $9.71 billion, a price-to-earnings ratio of 17.44, a P/E/G ratio of 1.54 and a beta of 0.54. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The business's 50 day simple moving average is $87.87 and its 200-day simple moving average is $88.66.

Amdocs (NASDAQ:DOX - Get Free Report) last posted its earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, beating the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period last year, the company earned $1.62 earnings per share. The business's quarterly revenue was down 8.4% on a year-over-year basis. On average, equities analysts predict that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is 42.80%.

Analyst Ratings Changes

Several analysts recently weighed in on the company. Wolfe Research assumed coverage on Amdocs in a research report on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a research report on Sunday, August 10th. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $105.33.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.